Elicio Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Elicio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Elicio Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Elicio Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.2M | 474k | 10.94 |
| 2025-06-30 | $3.5M | 455k | 7.72 |
| 2025-03-31 | $2.0M | 322k | 6.16 |
| 2024-12-31 | $1.2M | 246k | 4.90 |
| 2024-09-30 | $1.2M | 245k | 5.03 |
| 2024-06-30 | $930k | 226k | 4.11 |
| 2024-03-31 | $1.6M | 216k | 7.60 |
| 2023-12-31 | $1.5M | 175k | 8.34 |
| 2023-09-30 | $1.2M | 141k | 8.45 |
| 2023-06-30 | $672k | 71k | 9.50 |